5 (575) · $ 19.00 · In stock
PDF) Anti-synthetase syndrome is associated with a higher risk of hospitalization among patients with idiopathic inflammatory myopathy and COVID-19
Idiopathic inflammatory myopathies: current insights and future frontiers - ScienceDirect
Frontiers Targeting intracellular pathways in idiopathic inflammatory myopathies: A narrative review
Frontiers Immune-mediated lung diseases: A narrative review
Frontiers Autoantibodies in the pathogenesis of idiopathic inflammatory myopathies: Does the endoplasmic reticulum stress response have a role?
Frontiers Toll-Like Receptor Signaling and Its Role in Cell
/ijms/ijms-22-07299/article_deploy/htm
Antibody Therapies in Autoimmune Inflammatory Myopathies: Promising Treatment Options
Frontiers High-Dimensional Analysis Reveals Distinct Endotypes in Patients With Idiopathic Inflammatory Myopathies
Frontiers Anti-synthetase syndrome is associated with a higher risk of hospitalization among patients with idiopathic inflammatory myopathy and COVID-19
Novel Insights into the Use of Biologicals in Idiopathic Inflammatory Myopathies
Frontiers The Role of Immune Checkpoint Molecules on Macrophages